Condensed Consolidated Statements of Changes in Stockholders’ Equity (Unaudited) - USD ($) $ in Thousands	Common Stock	Additional Paid-In Capital	Accumulated Deficit	Total
Balance at Dec. 31, 2022	$ 26	$ 355,220	$ (288,765)	$ 66,481
Balance (in Shares) at Dec. 31, 2022	25,674,823
Stock-based compensation		993		993
Sale of common stock, net of offering costs		770		770
Sale of common stock, net of offering costs (in Shares)	54,414
Issuance of common stock from exercise of stock options		1		1
Issuance of common stock from exercise of stock options (in Shares)	133
Net loss			(11,037)	(11,037)
Balance at Mar. 31, 2023	$ 26	356,984	(299,802)	57,208
Balance (in Shares) at Mar. 31, 2023	25,729,370
Balance at Dec. 31, 2022	$ 26	355,220	(288,765)	66,481
Balance (in Shares) at Dec. 31, 2022	25,674,823
Net loss				(39,494)
Balance at Sep. 30, 2023	$ 27	371,815	(328,259)	43,583
Balance (in Shares) at Sep. 30, 2023	27,413,441
Balance at Mar. 31, 2023	$ 26	356,984	(299,802)	57,208
Balance (in Shares) at Mar. 31, 2023	25,729,370
Stock-based compensation		1,001		1,001
Sale of common stock, net of offering costs	$ 1	9,787		9,788
Sale of common stock, net of offering costs (in Shares)	1,210,965
Issuance of common stock from exercise of stock options		261		261
Issuance of common stock from exercise of stock options (in Shares)	44,108
Net loss			(15,181)	(15,181)
Balance at Jun. 30, 2023	$ 27	368,033	(314,983)	53,077
Balance (in Shares) at Jun. 30, 2023	26,984,443
Stock-based compensation		921		921
Stock-based compensation (in Shares)	13,144
Sale of common stock, net of offering costs		2,861		2,861
Sale of common stock, net of offering costs (in Shares)	415,854
Net loss			(13,276)	(13,276)
Balance at Sep. 30, 2023	$ 27	371,815	(328,259)	43,583
Balance (in Shares) at Sep. 30, 2023	27,413,441
Balance at Dec. 31, 2023	$ 28	373,934	(337,583)	36,379
Balance (in Shares) at Dec. 31, 2023	27,634,213
Stock-based compensation		1,378		1,378
Sale of common stock, net of offering costs	$ 1	14,694		14,695
Sale of common stock, net of offering costs (in Shares)	1,752,050
Issuance of common stock from exercise of stock options		75		75
Issuance of common stock from exercise of stock options (in Shares)	10,148
Net loss			(8,670)	(8,670)
Balance at Mar. 31, 2024	$ 29	390,081	(346,253)	43,857
Balance (in Shares) at Mar. 31, 2024	29,396,411
Balance at Dec. 31, 2023	$ 28	373,934	(337,583)	$ 36,379
Balance (in Shares) at Dec. 31, 2023	27,634,213
Issuance of common stock from exercise of stock options (in Shares)				10
Net loss				$ (31,591)
Balance at Sep. 30, 2024	$ 31	407,351	(369,174)	38,208
Balance (in Shares) at Sep. 30, 2024	31,195,891
Balance at Mar. 31, 2024	$ 29	390,081	(346,253)	43,857
Balance (in Shares) at Mar. 31, 2024	29,396,411
Stock-based compensation		1,374		1,374
Sale of common stock, net of offering costs	$ 2	9,955		9,957
Sale of common stock, net of offering costs (in Shares)	1,154,191
Net loss			(11,353)	(11,353)
Balance at Jun. 30, 2024	$ 31	401,410	(357,606)	43,835
Balance (in Shares) at Jun. 30, 2024	30,550,602
Stock-based compensation		1,337		1,337
Stock-based compensation (in Shares)	13,394
Sale of common stock, net of offering costs		4,604		4,604
Sale of common stock, net of offering costs (in Shares)	631,895
Net loss			(11,568)	(11,568)
Balance at Sep. 30, 2024	$ 31	$ 407,351	$ (369,174)	$ 38,208
Balance (in Shares) at Sep. 30, 2024	31,195,891